<b>Background and purpose:</b> The role of adjuvant radiation therapy (RT) in early-stage HER2-positive breast cancer treated with breast-conserving surgery (BCS) and systemic therapy remains uncertain in the era of HER2-targeted regimens. The gene discussed is ERBB2; the disease is breast cancer.